Ricky Sun - 09 Jun 2021 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Reporting relationship: Director
Issuer ticker: ARQT
Reported as of: 09 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Jun 2021, 17:30:15 UTC
Prior SEC filing: 04 Jun 2021
Next SEC filing: 15 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Ricky Sun

Key filing fact

Ricky Sun filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 11 Jun 2021.

Key facts

This page summarizes Ricky Sun's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Jun 2021, 17:30.

Change

Previous filing in this sequence was filed on 04 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARQT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +13,391
Change %
Price: $0.000000
Shares after: 13,391
Date: 09 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,391
Exercise price: $27.77
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of (i) the first anniversary of June 9, 2021 or (ii) the next Annual Meeting following June 9, 2021, subject to Reporting Person's continuous service as a director until such vesting date.